Home › Funds › American Century › Avantis U.S. Small Cap Equity Fund
Fund family: American Century · Filed by AMERICAN CENTURY ETF TRUST (CIK 1710607) · SEC series S000085331
Share classes and tickers: AVSBX (C000250326), AVSCX (C000250327)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 8,645 with, 32 against, 0 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 17 FOR, 11 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as American Century’s manager page (564,755 ballot items across 76 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | American Century | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 86.0% | 8,428 | 88.0% | 451,178 |
| Backed environmental and social shareholder proposals at US companies | n/a | 7 | 2.0% | 2,319 |
Each ballot item this fund voted is set against the votes of the other American Century funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most American Century funds on 1 item (0.1% of the 7,781 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most American Century funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Veeco Instruments Inc. | 2026-02-06 | To approve, on a non-binding, advisory basis, the compensation that will be paid or become payable to the named executive officers of Veeco that is based on or otherwise relates to the transactions contemplated by the Merger Agreement; and | Against | FOR — 6 of 9 American Century funds | Against | Approved, 98.9% support |
Download all 1 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 95.5% of this fund’s 8,677 such votes could be given a sector; the other 387 (4.5%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 2,239 | 0 | 0.0% |
| Consumer Discretionary | 1,992 | 18 | 0.9% |
| Industrials | 1,125 | 2 | 0.2% |
| Health Care | 941 | 10 | 1.1% |
| Technology | 769 | 1 | 0.1% |
| Energy | 436 | 0 | 0.0% |
| Consumer Staples | 193 | 1 | 0.5% |
| Utilities | 182 | 0 | 0.0% |
| Telecommunications | 145 | 0 | 0.0% |
| Basic Materials | 124 | 0 | 0.0% |
| Miscellaneous | 78 | 0 | 0.0% |
| Real Estate | 66 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 6,040 | 12 |
| Say-on-Pay | 1,034 | 0 |
| Audit-related | 960 | 0 |
| Compensation | 340 | 0 |
| Corporate Governance | 199 | 9 |
| Extraordinary Transactions | 105 | 1 |
| Capital Structure | 60 | 2 |
| Shareholder Rights and Defenses | 30 | 1 |
| Environment or Climate | 4 | 4 |
| Diversity, Equity, and Inclusion | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Viavi Solutions Inc. | November 12, 2025 | $892,325 | 13 | 0 |
| Victoria's Secret & Co. | June 11, 2026 | $771,234 | 11 | 0 |
| Marqeta, Inc. | June 10, 2026 | $647,645 | 8 | 0 |
| Oscar Health, Inc. | June 4, 2026 | $629,670 | 10 | 0 |
| Frontdoor, Inc. | May 13, 2026 | $614,829 | 10 | 0 |
| ViaSat, Inc. | September 4, 2025 | $604,814 | 6 | 0 |
| Abercrombie & Fitch Co. | June 3, 2026 | $603,614 | 11 | 0 |
| Ligand Pharmaceuticals Incorporated | June 5, 2026 | $582,602 | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 5, 2026 | SkyWest, Inc. | A shareholder proposal regarding collective bargaining policy. Shareholder proposal | For | Against |
| May 21, 2026 | Harley-Davidson, Inc. | To vote on a shareholder proposal regarding a climate transition plan. Shareholder proposal | Against | For |
| April 22, 2026 | Dana Incorporated | Shareholder proposal to require an independent Board Chairman. Shareholder proposal | Against | For |
| April 24, 2026 | ArcBest Corporation | A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | Against | For |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Jordan R. Asher | For | Against |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Claudia N. Drayton | For | Against |
| May 7, 2026 | Wolverine World Wide, Inc. | Shareholder proposal regarding new climate change polices or practices. Shareholder proposal | Against | For |
| April 15, 2026 | Sonoco Products Company | Advisory (non-binding) shareholder proposal - avoid brand damage from political spending. Shareholder proposal | Against | For |
| June 16, 2026 | PENN Entertainment, Inc. | Advisory vote on a shareholder proposal regarding the annual election of directors, if properly presented. Shareholder proposal | For | Against |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are elected and qualified: DOMA Nominees: Oliver Benton "Ben" Curtis III Shareholder proposal | For | Against |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are elected and qualified: DOMA Nominees: Eric de Armas Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (7 in 2025-2026), and how the fund voted the items on its ballot.
8,776 ballot items at 1,061 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Avantis U.S. Small Cap Equity Fund (AVSBX) voted at 1,061 shareholder meetings of 1,019 companies, on 8,776 ballot items in all. Where management made a recommendation, the fund followed it on 99.6% of the items and voted against it 32 times. Its most frequent area of disagreement was director elections (12 of its votes against management). It voted on 33 shareholder proposals. It voted FOR the board's own proposals less often than American Century's funds as a whole (86.0% against 88.0%). It voted differently from most American Century funds on 1 item. 7 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of American Century’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.